Glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006340002 (hide)

Owner Eli Lilly and Company

Inventors Zhu, Guoxin; Conner, Scott Eugene; Li, Jianke

Agent Spruson & Ferguson

Pub. Number AU-B-2006340002

PCT Pub. Number WO2007/106181

Priority 60/737,627 17.11.05 US

Filing date 7 November 2006

Wipo publication date 20 September 2007

Acceptance publication date 22 December 2011

International Classifications

C07C 237/36 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/106181 Priority application(s): WO2007/106181

22 December 2011 Application Accepted

  Published as AU-B-2006340002

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006340003-Process for making pharmaceutical compositions with a transient plasticizer

2006339995-Online syndicated content feed metrics